🇺🇸 FDA
Pipeline program

Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.

SPD465-303

Phase 3 small_molecule completed

Quick answer

Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate. for Attention Deficit Disorder With Hyperactivity is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Attention Deficit Disorder With Hyperactivity
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials